The product is codenamed VR730, and Hikma will be responsible for the clinical development, manufacture and commercialisation of the salmeterol generic, delivered via Vectura's dry powder inhaler.
The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler ... Sandoz generics arm, and Hikma have tried unsuccessfully to get copies ...